Tempus AI Gears Up For Q2 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts
1. TEM reports Q2 earnings on August 8; expects losses to improve significantly. 2. Projected revenue of $297.76 million versus $165.97 million last year. 3. TEM received FDA clearance for ejection fraction software on July 16. 4. Analysts have mixed ratings; price targets range from $55 to $74. 5. Shares rose 5.8% to $58.74 prior to earnings announcement.